ZA947338B - Use of angiotensin II and analogs thereof in tissue repair - Google Patents

Use of angiotensin II and analogs thereof in tissue repair

Info

Publication number: ZA947338B
Authority: ZA; South Africa
Prior art keywords: analogs; angiotensin; tissue repair; wound healing; compositions
Prior art date: 1993-09-24

Application number

ZA947338A

Other languages

English (en)

Inventor

Kathleen R Rodgers

Gere Stodder Dizerega

Original Assignee

Univ Southern California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-24

Filing date

1994-09-21

Publication date

1995-05-10

1994-09-21 Application filed by Univ Southern California filed Critical Univ Southern California

1995-05-10 Publication of ZA947338B publication Critical patent/ZA947338B/xx

Links

102000005862 Angiotensin II Human genes 0.000 title 1
101800000733 Angiotensin-2 Proteins 0.000 title 1
CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 title 1
229950006323 angiotensin ii Drugs 0.000 title 1
230000017423 tissue regeneration Effects 0.000 title 1
230000029663 wound healing Effects 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
QMMRCKSBBNJCMR-KMZPNFOHSA-N Angiotensin III Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCN=C(N)N)C(C)C)C1=CC=C(O)C=C1 QMMRCKSBBNJCMR-KMZPNFOHSA-N 0.000 abstract 1
101800000738 Angiotensin-3 Proteins 0.000 abstract 1
102400000348 Angiotensin-3 Human genes 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Vascular Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA947338A 1993-09-24 1994-09-21 Use of angiotensin II and analogs thereof in tissue repair ZA947338B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US12636893A	1993-09-24	1993-09-24

Publications (1)

Publication Number	Publication Date
ZA947338B true ZA947338B (en)	1995-05-10

Family

ID=22424455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA947338A ZA947338B (en)	1993-09-24	1994-09-21	Use of angiotensin II and analogs thereof in tissue repair

Country Status (13)

Country	Link
US (1)	US5629292A (xx)
EP (1)	EP0730465B1 (xx)
JP (1)	JPH09502977A (xx)
AT (1)	ATE210677T1 (xx)
AU (1)	AU706333B2 (xx)
CA (1)	CA2172493C (xx)
DE (1)	DE69429450T2 (xx)
DK (1)	DK0730465T3 (xx)
ES (1)	ES2168312T3 (xx)
PT (1)	PT730465E (xx)
TW (1)	TW311088B (xx)
WO (1)	WO1995008337A1 (xx)
ZA (1)	ZA947338B (xx)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5955430A (en) *	1993-09-24	1999-09-21	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
AU758319B2 (en) *	1994-11-14	2003-03-20	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
US6528483B2 (en)	1995-06-07	2003-03-04	André Beaulieu	Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en)	1995-06-07	2006-09-26	Andre Beaulieu	Solid wound healing formulations containing fibronectin
MY121607A (en) *	1995-07-10	2006-02-28	Hyundai Curitel Inc	Grid moving method of object image and apparatus using the same and compaction/motion estimation method using the same and apparatus thereof
US6110895A (en) *	1996-12-16	2000-08-29	University Of Southern California	Method of promoting healing in skin grafts
EP1410801B1 (en)	1997-01-28	2013-04-10	University Of Southern California	Method for promoting hematopoietic cell proliferation and differentiation
US6335195B1 (en) *	1997-01-28	2002-01-01	Maret Corporation	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
WO1998033813A2 (en) *	1997-02-04	1998-08-06	University Of Southern California	Method for accelerating healing of thermal injuries
US6197751B1 (en)	1997-11-10	2001-03-06	The United States Of America As Represented By The Department Of Health And Human Services	Thymosin α1 promotes tissue repair, angiogenesis and cell migration
CA2310852A1 (en) *	1997-11-26	1999-06-03	University Of Southern California	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
US6248587B1 (en)	1997-11-26	2001-06-19	University Of Southern Cailfornia	Method for promoting mesenchymal stem and lineage-specific cell proliferation
US6165978A (en) *	1997-12-12	2000-12-26	University Of Southern California	Wound healing composition
EP1053004A2 (en)	1998-02-09	2000-11-22	University Of Southern California	Use of angiotensin analogues for promoting erythropoiesis
US6455500B1 (en)	1998-03-10	2002-09-24	University Of Southern California	Radiation therapy methods
US7173011B2 (en)	2000-11-20	2007-02-06	University Of Southern California	Radiation therapy methods
WO1999046285A2 (en)	1998-03-11	1999-09-16	University Of Southern California	Method of promoting production of living tissue equivalents
CA2324988A1 (en) *	1998-04-09	1999-10-21	University Of Southern California	Methods for treatment and prevention of infections
US6762167B1 (en)	1998-05-11	2004-07-13	University Of Southern California	Methods for treating a patient undergoing chemotherapy
ATE292976T1 (de)	1998-05-11	2005-04-15	Univ Southern California	Verwendung von angiotensin analogen zur herstellung eines arzneimittels zur steigerung des ueberlebens der weissen blutzellen und mobilisierung von haematopoietischen stammzellen nach einer chemotherapeutischen behandlung
JP3686335B2 (ja)	1998-07-13	2005-08-24	ユニヴァースティオブサザーンカリフォルニア	骨および軟骨成長と修復を促進する方法
US6916783B2 (en)	1998-07-13	2005-07-12	University Of Southern California	Methods for accelerating bone and cartilage growth and repair
EP1105149A1 (en)	1998-08-13	2001-06-13	University Of Southern California	Methods to increase blood flow to ischemic tissue
ES2233284T3 (es)	1999-02-17	2005-06-16	Pfizer Products Inc.	Proteinas de fusion que comprenden portadores que pueden inducir una bdoble respuesta inmune.
US6730775B1 (en)	1999-03-23	2004-05-04	University Of Southern California	Methods for limiting scar and adhesion formation
US7338938B2 (en)	1999-05-10	2008-03-04	University Of Southern California	Methods for treating a patient undergoing chemotherapy
US6821953B1 (en) *	1999-12-16	2004-11-23	University Of Southern California	Methods for treating and preventing damage to mucosal tissue
US6747008B1 (en)	2000-06-19	2004-06-08	University Of Southern California	Methods for treating and preventing alopecia
CA2430010A1 (en)	2000-11-30	2002-06-06	University Of Florida	Treatments for neurogenetic disorders, impulse control disorders, and wound healing
AU2002308522A1 (en) *	2001-05-01	2002-11-11	University Of Southern California	Methods for inhibiting tumor cell proliferation
US20100204143A1 (en) *	2007-09-11	2010-08-12	Dorian Bevec	Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent
WO2009043451A2 (en) *	2007-09-11	2009-04-09	Mondobiotech Laboratories Ag	Use of chorionic gonadotropin-beta (109-145) as a therapeutic agent
WO2009033820A2 (en) *	2007-09-11	2009-03-19	Mondobiotech Laboratories Ag	Use of a peptide as a therapeutic agent
RU2010114006A (ru) *	2007-09-11	2011-10-20	Мондобайотек Лабораториз Аг (Li)	Применение пептида в качестве терапевтического средства
KR20100058553A (ko) *	2007-09-11	2010-06-03	몬도바이오테크 래보래토리즈 아게	치료제로서의 뉴로펩티드 ｓｆ 단독 또는 ｇｌｐ－２와의 배합물의 용도
US20090227507A1 (en) *	2008-03-10	2009-09-10	University Of Southern California	Angiotensin (1-7) Dosage Forms and Uses Thereof
CA2748340C (en)	2008-12-29	2017-01-24	Trevena, Inc.	.beta.-arrestin effectors and compositions and methods of use thereof
BR112013019513A2 (pt)	2011-02-02	2019-06-11	Univ Southern California	métodos para o tratamento de úlceras diabéticas do pé
MX2014009233A (es)	2012-01-31	2015-05-15	Trevena Inc	Efectores de beta-arrestina y composiciones y metodos de uso de la misma.
US8557958B1 (en)	2012-06-18	2013-10-15	Tarix Pharmaceuticals Ltd.	Compositions and methods for treatment of diabetes
US8633158B1 (en)	2012-10-02	2014-01-21	Tarix Pharmaceuticals Ltd.	Angiotensin in treating brain conditions
CN105873598A (zh)	2013-07-03	2016-08-17	代表亚利桑那大学的亚利桑那校董会	用于治疗认知功能障碍的方法
US9518086B2 (en)	2014-02-07	2016-12-13	Trevena, Inc.	Crystalline and amorphous forms of a β-arrestin effector
US9333233B2 (en)	2014-02-25	2016-05-10	Tarix Pharmaceuticals Ltd.	Methods and compositions for the delayed treatment of stroke
AU2015264367A1 (en)	2014-05-19	2016-12-15	Trevena, Inc.	Synthesis of Beta-Arrestin Effectors
WO2016014342A2 (en)	2014-07-21	2016-01-28	Arizona Board Of Regents For The University Of Arizona	Ang-(1-7) derviative oligopeptides and methods for using and producing the same
US10183055B2 (en)	2014-07-21	2019-01-22	Arizona Board Of Regents On Behalf Of The University Of Arizona	Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
US10960045B2 (en) *	2015-10-14	2021-03-30	Constant Therapeutics Llc	Methods and compositions for the treatment of epidermolysis bullosa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3886134A (en) *	1970-03-09	1975-05-27	Morton Norwich Products Inc	Analogues of angiotensin II
US5015629A (en) *	1989-06-26	1991-05-14	University Of Southern California	Tissue repair

1994
- 1994-09-19 DE DE69429450T patent/DE69429450T2/de not_active Expired - Fee Related
- 1994-09-19 CA CA002172493A patent/CA2172493C/en not_active Expired - Lifetime
- 1994-09-19 ES ES94928150T patent/ES2168312T3/es not_active Expired - Lifetime
- 1994-09-19 PT PT94928150T patent/PT730465E/pt unknown
- 1994-09-19 WO PCT/US1994/010503 patent/WO1995008337A1/en active IP Right Grant
- 1994-09-19 EP EP94928150A patent/EP0730465B1/en not_active Expired - Lifetime
- 1994-09-19 AU AU77302/94A patent/AU706333B2/en not_active Ceased
- 1994-09-19 AT AT94928150T patent/ATE210677T1/de not_active IP Right Cessation
- 1994-09-19 DK DK94928150T patent/DK0730465T3/da active
- 1994-09-19 JP JP7509853A patent/JPH09502977A/ja not_active Ceased
- 1994-09-21 ZA ZA947338A patent/ZA947338B/xx unknown
- 1994-11-05 TW TW083110297A patent/TW311088B/zh active
- 1994-11-14 US US08/337,781 patent/US5629292A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
PT730465E (pt)	2002-06-28
EP0730465A1 (en)	1996-09-11
ATE210677T1 (de)	2001-12-15
DE69429450T2 (de)	2002-07-25
CA2172493A1 (en)	1995-03-30
US5629292A (en)	1997-05-13
JPH09502977A (ja)	1997-03-25
AU706333B2 (en)	1999-06-17
TW311088B (xx)	1997-07-21
AU7730294A (en)	1995-04-10
EP0730465B1 (en)	2001-12-12
DK0730465T3 (da)	2002-04-08
EP0730465A4 (en)	1997-11-12
WO1995008337A1 (en)	1995-03-30
DE69429450D1 (de)	2002-01-24
ES2168312T3 (es)	2002-06-16
CA2172493C (en)	2003-09-16

Publication	Publication Date	Title
ZA947338B (en)	1995-05-10	Use of angiotensin II and analogs thereof in tissue repair
MX9703609A (es)	1997-08-30	Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido.
ZA947337B (en)	1995-05-10	Use of angiotensin II analogs in tissue repair
CA2221730A1 (en)	1996-12-12	Use of angiotensin ii type 2 receptor agonists in tissue repair
DE69430440D1 (de)	2002-05-23	Zusammensetzungen zur inhibition von retroviraler verbreitung, die 2',3'-dideoxy-inosin und hydroxyharnstoff enthalten
NZ308293A (en)	2000-01-28	Antibacterial-wound healing compositions comprising a pyruvate, antioxidant and fatty acids
DE69824445D1 (de)	2004-07-15	Zusammensetzungen zur wundheilung
AU3435497A (en)	1998-01-14	Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
NZ295303A (en)	1999-07-29	Sunscreen composition comprising a sunscreen agent, an anti-inflammatory agent and a composition for healing wounds
NO971889D0 (no)	1997-04-24	Forbindelser og sammensetninger for levering av aktive midler
DE60040753D1 (de)	2008-12-18	Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
PL317195A1 (en)	1997-03-17	Application of agents in the form of gel as dressing compositions
CA2147123A1 (en)	1994-04-28	Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo
ES2221950T3 (es)	2005-01-16	Dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
IL127379A0 (en)	1999-10-28	Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
BR9611472A (pt)	1999-02-02	Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
CA2364027A1 (en)	2000-09-21	Iodine preparation composition
UY26514A1 (es)	2001-07-31	" composición para el tratamiento de tejidos danados".
IL106288A0 (en)	1993-11-15	Skin regenerating cosmetic compositions
MX9709983A (es)	1998-03-29	El uso de agonistas receptores tipo 2 de angiotesina ii en la preparacion de composiciones para la preparacion de tejidos.
LT96094A (en)	1996-12-27	The active ingredient of pharmaceutical composition for treating constipation
MX9701606A (es)	1998-04-30	Terapia de combinacion para evitar la perdida osea-progesterona y agonistas de estrogeno.
AR018360A1 (es)	2001-11-14	Una composicion para el tratamiento del cabello y su uso
BG101526A (en)	1998-01-30	Antiphlogistic composition for external application
ES2165366T3 (es)	2002-03-16	Procedimientos y composiciones para inhibir la inflamacion mediada por celulas endoteliales y fibrinogeno.